Explore more publications!
Healthy Living Washington
Got News to Share?

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on March 12, 2026

Free Training Day for Professionals, Parents, and the Community: Learn to Recognize Child Trafficking and Exploitation
Mar. 12, 2026

Free Training Day for Professionals, Parents, and the Community: Learn to Recognize Child Trafficking and Exploitation

Indeterminate EIN Presswire
The ‘No-Break’ Culture in Nursing Is a Mental Health Crisis - Not a Badge of Honor
Mar. 12, 2026

The ‘No-Break’ Culture in Nursing Is a Mental Health Crisis - Not a Badge of Honor

Indeterminate EIN Presswire
International Long COVID Awareness Day 2026 Highlights Ongoing Impact of Long COVID
Mar. 12, 2026

International Long COVID Awareness Day 2026 Highlights Ongoing Impact of Long COVID

Indeterminate EIN Presswire
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
Mar. 12, 2026

VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results

Indeterminate GlobeNewswire
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
Mar. 12, 2026

Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

Indeterminate GlobeNewswire
GlycoPezil Supplement Claims Evaluated - Complete Investigation of the Blood Sugar Support Ingredients
Mar. 12, 2026

GlycoPezil Supplement Claims Evaluated - Complete Investigation of the Blood Sugar Support Ingredients

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Mar. 12, 2026

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Mar. 12, 2026

BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026

Indeterminate GlobeNewswire
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Mar. 12, 2026

Precipio Announces Q4 and year-end 2025 Shareholder Update Call

Indeterminate GlobeNewswire
Where AI Agents Fit in Healthcare Operations
Mar. 12, 2026

Where AI Agents Fit in Healthcare Operations

Indeterminate GlobeNewswire
Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Mar. 12, 2026

Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Indeterminate GlobeNewswire
Cellectis publiera ses résultats financiers du quatrième trimestre et de l’année 2025 le 19 mars 2026
Mar. 12, 2026

Cellectis publiera ses résultats financiers du quatrième trimestre et de l’année 2025 le 19 mars 2026

Indeterminate GlobeNewswire
Voting Rights and Shares Capital of the Company
Mar. 12, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Mar. 12, 2026

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire
NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange
Mar. 12, 2026

NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

Indeterminate GlobeNewswire
Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
Mar. 12, 2026

Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Indeterminate GlobeNewswire
­­Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Mar. 12, 2026

­­Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results

Indeterminate GlobeNewswire
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 12, 2026

TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar. 12, 2026

Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
Mar. 12, 2026

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions